FOXN3 and melanoma: A study in liver and melanoma malignancy cells (where FOXN3 expression has been reported to be decreased compared to corresponding normal tissue) showed that FOXN3 protein can act on the SKIP through its COOH terminal, repressing SKIP mediated TGF-β signaling (42).